A Phase I/II Trial of Chidamide Decitabine and Immune Checkpoint Inhibitors in Relapsed/Refractory Non-Hodgkin Lymphoma and Advanced Solid Tumors
Latest Information Update: 14 Apr 2022
At a glance
- Drugs Decitabine (Primary) ; Tucidinostat (Primary) ; Immune checkpoint protein inhibitors
- Indications Non-Hodgkin's lymphoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 14 Apr 2022 New trial record